Scarica l'app Stockscreener
1.20
1.69%
0.02
Dopo l'orario di chiusura:
1.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BNGO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.18
Aprire:
$1.18
Volume 24 ore:
288.07K
Relative Volume:
2.10
Capitalizzazione di mercato:
$14.13M
Reddito:
$28.74M
Utile/perdita netta:
$-31.60M
Rapporto P/E:
-0.2362
EPS:
-5.0805
Flusso di cassa netto:
$-19.30M
1 W Prestazione:
-3.23%
1M Prestazione:
+3.45%
6M Prestazione:
+6.19%
1 anno Prestazione:
-75.61%
Intervallo 1D:
$1.16
$1.24
Intervallo di 1 settimana:
$1.16
$1.25
Portata 52W:
$1.00
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
Nome
Bionano Genomics Inc
Settore
Industria
Telefono
(858) 888-7600
Indirizzo
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.20 | 13.90M | 28.74M | -31.60M | -19.30M | -5.0805 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-12 | Ripresa | BTIG Research | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2021-06-16 | Iniziato | BTIG Research | Buy |
| 2020-09-24 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-08 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times
Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan
Bionano Laboratories Announces New York State Department of - globenewswire.com
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media
Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - valueresearchonline.com
Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - valueresearchonline.com
Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan
Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com
Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Gossamer Bio: Q2 Earnings Snapshot - AOL.com
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingView
Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100 - GuruFocus
Transcript : Bionano Genomics, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up - Investing.com
Bionano Genomics raises FY26 sales guidance range - scanx.trade
Q2 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano Genomics Q2 revenue rises on increased clinical adoption - TradingView
BNGO: Q2 2026 revenue rose 21% but liquidity concerns threaten ongoing operations - TradingView
Bionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingView
Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingView
Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning - Stock Titan
BRIEF-Bionano Genomics Q2 Revenue USD 8.2 Million - TradingView
Bionano Genomics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Bionano Genomics (NASDAQ:BNGO): What Could Today’s Update Reveal About Adoption And Liquidity Ahead Of The Update? - Kalkine Media
BNGO: Q2 2026 revenue rose 21% to $8.2M, with margin gains and raised full-year guidance - TradingView
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):